All News

J&J Shareholders Urged by Others to Reject CEO's $

Johnson & Johnson Chief Executive Officer Alex Gorsky is up for a whopping $30 million payday. Howev
Read More

KalVista's Hereditary Angioedema Trial On Hold as

The U.S. Food and Drug Administration (FDA) has placed a clinical hold on KalVista Pharmaceuticals’
Read More

Humanigen’s Cytokine Storm Control Drug Shows Posi

Burlingame, California-based Humanigen reported positive data from its Phase Ib ZUMA-19 trial of len
Read More

Amgen Awarded Breakthrough Designation for Acquire

One month after snapping up Five Prime Therapeutics and its Phase III ready anti-FGFR2b antibody bem
Read More

Vertex Drops $900 Million to Expand Partnership wi

Vertex Pharmaceuticals has expanded its collaborative partnership with CRISPR Therapeutics to develo
Read More

Takeda reiterates commitment to supporting patient

Head of Market Access and Pricing, Takeda India, said, “Takeda is a patient-focused organisation and
Read More

RTPCR tests in use in India do not miss UK, Brazil

The release mentions that the COVID-19 virus has been mutating and various mutations have been found
Read More


;